Literature DB >> 31976863

Coronary Artery Target Selection and Survival After Bilateral Internal Thoracic Artery Grafting.

Faisal G Bakaeen1, Kirthi Ravichandren2, Eugene H Blackstone3, Penny L Houghtaling4, Edward G Soltesz2, Douglas R Johnston2, Stephanie L Mick2, José L Navia2, Michael Zhen-Yu Tong2, Kenneth R McCurry2, Rami Akhrass2, Mouin Abdallah5, Gösta B Pettersson2, Nicholas M Smedira2, Eric E Roselli2, A Marc Gillinov2, Lars G Svensson2.   

Abstract

BACKGROUND: The importance of a coronary artery, based on the myocardial mass it perfuses, is well documented, but little is known about the importance of a vessel that has been bypassed and its effect on survival in the context of bilateral internal thoracic artery (BITA) grafting.
OBJECTIVES: This study determined the effect of a dominant left anterior descending (LAD) artery and important non-LAD targets on outcomes after BITA grafting.
METHODS: From January 1972 to January 2011, of 6,127 patients who underwent BITA grafting, 2,551 received 1 ITA grafted to the LAD and had an evaluable coronary angiogram. A dominant LAD was defined as one that was wrapped around the left ventricular apex. Non-LAD targets were graded based on their terminal reach toward the apex: important: >75% (n = 1,698); and less important: ≤75% (n = 853). Mean follow-up was 14 ± 8.7 years. Multivariable analysis was performed to identify risk factors for time-related mortality.
RESULTS: A dominant LAD was present more frequently in patients with less important additional targets (51% vs. 35%; p < 0.0001). A total of 179 patients (7.0%) received a second ITA to multiple targets, 77 (43%) of which were to multiple important target vessels. Unadjusted late survival was similar regardless of degree of importance of the second ITA target-77% at 15 years (p = 0.70) for the important and less important targets, respectively. In the multivariable model, grafting the second ITA to multiple important targets was associated with better long-term survival (p = 0.005). In patients with a nondominant LAD, a second ITA grafted to a less important artery was associated with higher risk of operative mortality (2.4% vs. 0.51%; p = 0.007). A saphenous vein graft to an important or less important target did not influence long-term survival.
CONCLUSIONS: In BITA grafting, bypassing multiple important targets to maximize myocardium supplied by ITAs improved long-term survival. In patients with a nondominant LAD, selecting an important target for the second ITA lowered operative mortality.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac surgery; coronary artery bypass grafting; ischemic heart disease; survival

Year:  2020        PMID: 31976863     DOI: 10.1016/j.jacc.2019.11.026

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  How to build a multi-arterial coronary artery bypass programme: a stepwise approach.

Authors:  Mario F L Gaudino; Sigrid Sandner; Giorgia Bonalumi; Jennifer S Lawton; Stephen E Fremes
Journal:  Eur J Cardiothorac Surg       Date:  2020-12-01       Impact factor: 4.191

2.  Reply: Not all incomplete revascularizations are created equal.

Authors:  Aaron J Weiss; Faisal G Bakaeen
Journal:  JTCVS Open       Date:  2021-08-20

3.  How decisive is the number of distal arterial anastomoses in coronary bypass surgery?

Authors:  Olivier J L Jegaden; Fadi Farhat; Margaux P O Jegaden; Amar O Hassan; Joel Lapeze; Armand Eker
Journal:  J Cardiothorac Surg       Date:  2021-01-07       Impact factor: 1.637

4.  Commentary: Beyond the horizon of evidence in robotic totally endoscopic coronary artery bypass grafting.

Authors:  Aaron J Weiss; William C Frankel; Faisal G Bakaeen
Journal:  JTCVS Tech       Date:  2021-04-27

5.  Robotic totally endoscopic coronary artery bypass grafting: It's now or never!

Authors:  Husam H Balkhy
Journal:  JTCVS Tech       Date:  2021-04-10

6.  Commentary: Total-arterial, anaortic revascularization, and the boutique practice of coronary surgery.

Authors:  Faisal G Bakaeen
Journal:  JTCVS Tech       Date:  2021-10-14

7.  Commentary: Coronary revascularization therapies and number needed to treat.

Authors:  Arnaldo Dimagli; Aaron J Weiss; Faisal G Bakaeen
Journal:  JTCVS Open       Date:  2022-01-20

8.  Intraoperative graft patency validation: Friend or foe?

Authors:  Rami Akhrass; Faisal G Bakaeen
Journal:  JTCVS Tech       Date:  2021-01-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.